Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Statistics

Total Valuation

Cathay Biotech has a market cap or net worth of CNY 37.43 billion. The enterprise value is 31.85 billion.

Market Cap	37.43B
Enterprise Value	31.85B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Jul 24, 2024

Share Statistics

Cathay Biotech has 720.66 million shares outstanding. The number of shares has increased by 0.07% in one year.

Current Share Class	n/a
Shares Outstanding	720.66M
Shares Change (YoY)	+0.07%
Shares Change (QoQ)	+3.87%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	17.80%
Float	251.86M

Valuation Ratios

The trailing PE ratio is 58.34 and the forward PE ratio is 73.15.

PE Ratio	58.34
Forward PE	73.15
PS Ratio	12.28
PB Ratio	1.77
P/TBV Ratio	2.22
P/FCF Ratio	1,122.99
P/OCF Ratio	54.00
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 43.81, with an EV/FCF ratio of 955.57.

EV / Earnings	61.17
EV / Sales	10.45
EV / EBITDA	43.81
EV / EBIT	78.92
EV / FCF	955.57

Financial Position

The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.08.

Current Ratio	5.10
Quick Ratio	4.46
Debt / Equity	0.08
Debt / EBITDA	2.22
Debt / FCF	49.08
Interest Coverage	16.87

Financial Efficiency

Return on equity (ROE) is 2.73% and return on invested capital (ROIC) is 1.31%.

Return on Equity (ROE)	2.73%
Return on Assets (ROA)	1.19%
Return on Invested Capital (ROIC)	1.31%
Return on Capital Employed (ROCE)	1.87%
Revenue Per Employee	1.76M
Profits Per Employee	300,088
Employee Count	1,735
Asset Turnover	0.14
Inventory Turnover	1.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.81% in the last 52 weeks. The beta is 0.66, so Cathay Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-4.81%
50-Day Moving Average	50.13
200-Day Moving Average	43.78
Relative Strength Index (RSI)	53.40
Average Volume (20 Days)	4,219,571

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cathay Biotech had revenue of CNY 3.05 billion and earned 520.65 million in profits. Earnings per share was 0.89.

Revenue	3.05B
Gross Profit	901.02M
Operating Income	413.47M
Pretax Income	582.26M
Net Income	520.65M
EBITDA	736.94M
EBIT	413.47M
Earnings Per Share (EPS)	0.89

Balance Sheet

The company has 10.80 billion in cash and 1.64 billion in debt, giving a net cash position of 9.16 billion or 12.71 per share.

Cash & Cash Equivalents	10.80B
Total Debt	1.64B
Net Cash	9.16B
Net Cash Per Share	12.71
Equity (Book Value)	21.15B
Book Value Per Share	29.50
Working Capital	10.41B

Cash Flow

In the last 12 months, operating cash flow was 693.14 million and capital expenditures -659.81 million, giving a free cash flow of 33.33 million.

Operating Cash Flow	693.14M
Capital Expenditures	-659.81M
Free Cash Flow	33.33M
FCF Per Share	0.05

Margins

Gross margin is 29.55%, with operating and profit margins of 13.56% and 17.08%.

Gross Margin	29.55%
Operating Margin	13.56%
Pretax Margin	19.10%
Profit Margin	17.08%
EBITDA Margin	24.17%
EBIT Margin	13.56%
FCF Margin	1.09%

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.77%.

Dividend Per Share	0.40
Dividend Yield	0.77%
Dividend Growth (YoY)	5.56%
Years of Dividend Growth	1
Payout Ratio	27.48%
Buyback Yield	-0.07%
Shareholder Yield	0.70%
Earnings Yield	1.39%
FCF Yield	0.09%

Stock Splits

The last stock split was on July 20, 2022. It was a forward split with a ratio of 1.4.

Last Split Date	Jul 20, 2022
Split Type	Forward
Split Ratio	1.4

Scores

Cathay Biotech has an Altman Z-Score of 5.14.

Altman Z-Score	5.14
Piotroski F-Score	n/a